Founded in 2014, Sim&Cure is French digital start-up focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite. The Sim&Size™ software is a Class II medical device with CE mark and FDA clearance that has already been used to treat more than 5,000 patients in 350 hospitals in the world.

Through several modules, Sim&Size™ is a software suite that provides to the physician a 3D visualization of medical images and a computational model of neurovascular implantable medical devices (IMDs). The therapeutic strategy is the most important step of this disease treatment and Sim&Size™ is now part of it by being efficient, safe, and reproducible. Computational modeling of specific devices in the anatomy of a patient helps the physician to achieve the intended outcome of the intervention.